BUZZ-Amneal Pharma gains as co poised to join S&P SmallCap index
I'm PortAI, I can summarize articles.
Amneal Pharmaceuticalsshares rose 3.4% to $14.30 as it prepares to join the S&P SmallCap 600 index, replacing TTM Technologies. Analysts expect passive funds to buy approximately 22.9 million AMRX shares, indicating strong demand. AMRX has a market cap of around $4 billion and has seen a 60% increase in share price over the past year. All five analysts rate the stock as a "buy" with a median price target of $15.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments